Improving Emergency Management of Status Epilepticus (SESIM)

University Hospital Basel

Status: Completed

Conditions: Status Epilepticus

Treatments: Other: No Pre-briefing; Other: Pre-briefing with the current SE treatment guidelines; Other: Pre-briefing with a consolidated "one page" SE treatment guide

Study type: Interventional

Funder types: Other

Identifiers

NCT03883516

Requ_2019-00168 me19Sutter3;

Details and patient eligibility

About

In the trial the effectiveness of pre-briefing physicians with the current guideline on Status epilepticus (SE) treatment or a consolidated "one page" guideline regarding quality enhancement of the physician's clinical performances is investigated.

Full description

Status epilepticus (SE) is a life-threatening neurological emergency defined as a state of continuous seizure or multiple seizures without full recovery of sensory, motor and/or cognitive function for at least 30 minutes. To achieve high quality management of SE, the American Epilepsy Society published an evidence-based guideline for the treatment of SE, which serves as reference for most national guidelines, but analyses regarding practicability, strict adherence, correct translation into clinical practice, and identification of recommended treatment steps at risk of being modified or missed are lacking. Simulator-based studies offer a platform for the design of standardized clinical scenarios that enable detailed investigations regarding the effect of the implementation and practicability of treatment guidelines.

This randomized controlled intervention study performed at the simulation center of the medical intensive care units (ICUs) at the University Hospital Basel is to investigate the effectiveness of pre-briefing physicians with both the current guideline on Status epilepticus (SE) treatment or a consolidated "one page" guideline regarding quality enhancement of the physicians' clinical performances..

Physicians from different medical specialties and with different duration of clinical experience will be enrolled. Participants will be randomly assigned to one of the following three pre-briefing groups: (1) no pre-briefing prior to the simulation training; (2) pre-briefing with the current SE treatment guidelines; (3) pre-briefing with the consolidated "one page" SE treatment guideline.

Enrollment: 124 patients

Sex: All

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Physicians from different medical specialties working at the University Hospital Basel

Exclusion criteria

• None

Trial design

Primary purpose: Health Services Research

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

124 participants in 3 patient groups, including a placebo group

No pre-briefing prior to the simulation training

Placebo Comparator group

Description:

No pre-briefing prior to the simulation training

Treatment:

Other: No Pre-briefing

Pre-briefing with the current SE treatment guidelines

Active Comparator group

Description:

pre-briefing with the current SE treatment Guidelines published by the American Epilepsy Society

Treatment:

Other: Pre-briefing with the current SE treatment guidelines

pre- briefing with consolidated SE treatment guideline

Active Comparator group

Description:

pre-briefing with the consolidated "one page" SE treatment guideline

Treatment:

Other: Pre-briefing with a consolidated "one page" SE treatment guide